ABVC BioPharma Inc (NASDAQ:ABVC) has a beta value of 0.33 and has seen 2.01 million shares traded in the last trading session. The company, currently valued at $17.12M, closed the last trade at $1.32 per share which meant it gained $0.26 on the day or 24.53% during that session. The ABVC stock price is -31.06% off its 52-week high price of $1.73 and 69.7% above the 52-week low of $0.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.36 million shares traded. The 3-month trading volume is 527.16K shares.
The consensus among analysts is that ABVC BioPharma Inc (ABVC) is Hold stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Sporting 24.53% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ABVC stock price touched $1.32 or saw a rise of 5.71%. Year-to-date, ABVC BioPharma Inc shares have moved 123.73%, while the 5-day performance has seen it change 91.86%. Over the past 30 days, the shares of ABVC BioPharma Inc (NASDAQ:ABVC) have changed 91.25%. Short interest in the company has seen 0.32 million shares shorted with days to cover at 0.24.
ABVC BioPharma Inc (ABVC) estimates and forecasts
The company’s shares have gained 92.06% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 12.78% over the past 5 years.
ABVC Dividends
ABVC BioPharma Inc is expected to release its next earnings report on 2023-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders
Insiders own 21.95% of the company shares, while shares held by institutions stand at 3.89% with a share float percentage of 4.98%. Investors are also buoyed by the number of investors in a company, with ABVC BioPharma Inc having a total of 15.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Jan 31, 2025 , the former fund manager holds about 0.39% shares in the company for having 51.24 shares of worth $67635.0 while later fund manager owns 46.95 shares of worth $61970.0 as of Dec 31, 2024 , which makes it owner of about 0.36% of company’s outstanding stock.
